Business

Cramer Pans Newspapers

On today's WALL STREET CONFIDENTIAL video on TheStreet.com, Cramer talked Gannett's (GCI) story about advertising not being that great.  Cramer noted the circulation is actually not going down that much, ...
Read Full Story »

Wal-Mart the Ex-Banker; They Still Don’t Get It

Wal-Mart (WMT) has withdrawn its Industrial loan charter application, in what is an obvious throwing in of the towel.  This will generate a sigh of relief among community bankers and ...
Read Full Story »

IPO’s For Private Equity & More Hedge Funds Coming

More and more discussions of IPO's for hedge funds and private equity firms are more forthcoming today.  Blackstone, one of the largest private equity players in the US, may be ...
Read Full Story »

Hollis Eden: What Else They Have Under the Hood

Hollis Eden (HEPH), a micro-cap drug development company, is up roughly 7% at $2.68 pre-market after the company announced it was officially shelving its Neumune radiation treatment development because of ...
Read Full Story »

Goldman Sachs Raised Starbucks & Cut McDonalds

Starbucks was ADDED to CONVICTION BUY LIST at Goldman Sachs.   Goldman sees 3 trewnds that can stem recent weakness and take it toward the $43 target. 1) trading reversal on ...
Read Full Story »

Nissan’s Carlos Ghosn: Hero No More

Carlos Ghosn was the global car industry's rock star. He turned around Nissan and then went to Europe and fixed Renault. He teamed with Kirk Kerkorian in an attempt to ...
Read Full Story »

Tobacco M&A: Where Is Phillip Morris (MO)

The company's slogan used to be "Call for Phillip Morris". Well, tobacco mergers and acquisitions are heating up and the world's largest company is silent.Imperial Tobacco (ITY) has already bought ...
Read Full Story »

Media Digest 3/16/2007 Reuters, WSJ, NYTimes, FT, Barron’s

According to Reuters, Carlos Ghosn will give up his responsibilities for the US and will focus on overseas markets for Nissan and Renault. Nissan is doing poorly in its home ...
Read Full Story »

Thursday’s Top Biotech & Medical Stocks

BiotechnologyMICROMET INC [MITI] +16.00% NEOSE TECH INC [NTEC] +13.14% TRUBION PHARMACEUTIC [TRBN] +8.91% CYPRESS BIOSCIENCE [CYPB] +8.80% OBAGI MEDICAL [OMPI] +8.02% Diagnostic SubstancesTORREYPINES THERAPEU [TPTX] +12.83% GENE LOGIC INC [GLGC] ...
Read Full Story »

Cramer’s SELL BLOCK All on Technology

On tonights MAD MONEY on CNBC, Jim Cramer did his SELL BLOCK and dedicated the entire segment to saying to sell technology and not look at it until later in ...
Read Full Story »

Cramer’s Non-Pharma Healthcare Pick

On tonight's MAD MONEY on CNBC, Jim Cramer said he has a defensive play that will cover you in a couple places.  Cramer was resuming his non-pharmaceutical healthcare stock sector.  ...
Read Full Story »

Another Defensive Stock From Cramer

On tonight's MAD MONEY on CNBC, Jim Cramer said he has a defensive play that will cover you in a couple places.  Cramer thinks that the buybacks are helping and ...
Read Full Story »

Cramer Defends Lenders & Has Two Buyout Speculations

On today's STOP TRADING segment on CNBC, Jim Cramer discussed Thuornburg Mortgage (TMA) and he said that the CEO is great and the shorts who are targeting him are wrong.  ...
Read Full Story »

Cramer Talks Brokers

On today's Wall Street Confidential video on TheStreet.com, Cramer unsurprisingly talked about the brokerage firm stocks now that all three reports in the group are out for the week.  He ...
Read Full Story »
Puppet

Viacom vs. Google: Who’s The Daddy?

From Internet Outsider The key question in the Viacom v. GooTube war is who-needs-whom more?  The best way to answer this question is to study the percentage of "views" on ...
Read Full Story »